Faegre Baker Daniels guided Craig-Hallum Capital Group as the sole managing underwriter for the $16.4 million initial public offering by DiaMedica, Therapeutics, Inc. of 4,100,000 shares of common stock. DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for neurological and kidney diseases. DiaMedica’s shares are listed on the TSX Venture Exchange under the trading symbol “DMA” and The Nasdaq Capital Market under the trading symbol “DMAC.”
Jonathan Zimmerman, Ben Stacke, Steve Conley and Kareem Tawfic led the deal team.
See DiaMedica's press release.